课题基金 / 基金详情

Therapeutic targetting of MIF in type 2 diabetes

Therapeutic targetting of MIF in type 2 diabetes
MIF 在 2 型糖尿病中的治疗靶点
批准号:
nhmrc : 494823
负责人:
A/Pr David Nikolic-Paterson
金额:
$34.65万
依托单位国家:
澳大利亚
项目类别:
NHMRC Project Grants
财政年份:
2008
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2008-01-01 至 2010-12-31

项目摘要

项目成果

A/Pr David Nikolic-Paterson的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
In this study, mouse models of disease will be used to determine the mechanisms by which the proinflammatory molecule called MIFpromotes the development of insulin resisitance and type 2 diabetes. We will also test whether therapeutic blockade of MIF can prevent the progression of disease in mice with established type 2 diabetes. Studies on tissue samples obtained from human patients will be used to confirm the human relevance of these findings.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
TGF-beta/Smad signalling in macrophage-mediated renal fibrosis.
  • 批准号:
    nhmrc : 1122073
  • 项目类别:
    Project Grants
  • 资助金额:
    $46.66万
  • 财政年份:
    2017
  • 负责人:
    A/Pr David Nikolic-Paterson
  • 依托单位:
Defining the central role of podocyte depletion in the development, progression and management of glomerular disease
  • 批准号:
    nhmrc : GNT1121793
  • 项目类别:
    Project Grants
  • 资助金额:
    $69.09万
  • 财政年份:
    2017
  • 负责人:
    A/Pr David Nikolic-Paterson
  • 依托单位:
Defining the central role of podocyte depletion in the development, progression and management of glomerular disease
  • 批准号:
    nhmrc : 1121793
  • 项目类别:
    Project Grants
  • 资助金额:
    $47.17万
  • 财政年份:
    2017
  • 负责人:
    A/Pr David Nikolic-Paterson
  • 依托单位:
TGF-beta/Smad signalling in macrophage-mediated renal fibrosis.
  • 批准号:
    nhmrc : GNT1122073
  • 项目类别:
    Project Grants
  • 资助金额:
    $68.37万
  • 财政年份:
    2017
  • 负责人:
    A/Pr David Nikolic-Paterson
  • 依托单位:
海外基金